ContextVision (CONTX) Stock Overview
A software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CONTX Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
ContextVision AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 4.15 |
| 52 Week High | NOK 6.60 |
| 52 Week Low | NOK 3.20 |
| Beta | 0.57 |
| 1 Month Change | 8.64% |
| 3 Month Change | -12.82% |
| 1 Year Change | -23.99% |
| 3 Year Change | -52.84% |
| 5 Year Change | -80.52% |
| Change since IPO | 12.16% |
Recent News & Updates
Recent updates
More Unpleasant Surprises Could Be In Store For ContextVision AB (publ)'s (OB:CONTX) Shares After Tumbling 25%
Nov 19
ContextVision AB (publ) (OB:CONTX) Just Reported, And Analysts Assigned A kr5.00 Price Target
Nov 09We Think That There Are More Issues For ContextVision (OB:CONTX) Than Just Sluggish Earnings
Sep 09Earnings Release: Here's Why Analysts Cut Their ContextVision AB (publ) (OB:CONTX) Price Target To kr5.00
Aug 30This Broker Just Slashed Their ContextVision AB (publ) (OB:CONTX) Earnings Forecasts
May 09There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings
Mar 04
Future Investments In POCUS And Asian Expansion Will Strengthen Market Presence
Expansion into Asian markets and integration with new customers will boost revenues via enhanced customer base and market presence.Subdued Growth No Barrier To ContextVision AB (publ) (OB:CONTX) With Shares Advancing 25%
Feb 25Is Now An Opportune Moment To Examine ContextVision AB (publ) (OB:CONTX)?
Feb 15There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings
Sep 02ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Mar 11ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear
Feb 22ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 18Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)
Jan 26When Should You Buy ContextVision AB (publ) (OB:CONTX)?
Jun 22Shareholder Returns
| CONTX | NO Healthcare Services | NO Market | |
|---|---|---|---|
| 7D | -1.0% | -2.0% | 1.9% |
| 1Y | -24.0% | -4.5% | 8.9% |
Return vs Industry: CONTX underperformed the Norwegian Healthcare Services industry which returned -4.5% over the past year.
Return vs Market: CONTX underperformed the Norwegian Market which returned 8.9% over the past year.
Price Volatility
| CONTX volatility | |
|---|---|
| CONTX Average Weekly Movement | 8.8% |
| Healthcare Services Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in NO Market | 11.3% |
| 10% least volatile stocks in NO Market | 2.6% |
Stable Share Price: CONTX's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: CONTX's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 44 | Gerald Potzsch | www.contextvision.com |
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women’s health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications.
ContextVision AB (publ) Fundamentals Summary
| CONTX fundamental statistics | |
|---|---|
| Market cap | NOK 312.52m |
| Earnings (TTM) | NOK 3.94m |
| Revenue (TTM) | NOK 118.65m |
Is CONTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CONTX income statement (TTM) | |
|---|---|
| Revenue | SEK 108.64m |
| Cost of Revenue | SEK 61.29m |
| Gross Profit | SEK 47.35m |
| Other Expenses | SEK 43.74m |
| Earnings | SEK 3.60m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 19, 2026
| Earnings per share (EPS) | 0.048 |
| Gross Margin | 43.58% |
| Net Profit Margin | 3.32% |
| Debt/Equity Ratio | 0% |
How did CONTX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/03 09:16 |
| End of Day Share Price | 2026/01/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ContextVision AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Juste Subataviciute | Norne Securities AS |
| Christian Lee | Pareto Securities |
| Klas Palin | Redeye |